{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:28:34Z","timestamp":1793035714222,"version":"4.5.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JASN"],"published-print":{"date-parts":[[2018,10]]},"abstract":"\n Background<\/jats:title>\n Estimating the prevalence of autosomal dominant polycystic kidney disease (ADPKD) is challenging because of age-dependent penetrance and incomplete clinical ascertainment. Early studies estimated the lifetime risk of ADPKD to be about one per 1000 in the general population, whereas recent epidemiologic studies report a point prevalence of three to five cases per 10,000 in the general population.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n To measure the frequency of high-confidence mutations presumed to be causative in ADPKD and autosomal dominant polycystic liver disease (ADPLD) and estimate lifetime ADPKD prevalence, we used two large, population sequencing databases, gnomAD (15,496 whole-genome sequences; 123,136 exome sequences) and BRAVO (62,784 whole-genome sequences). We used stringent criteria for defining rare variants in genes involved in ADPKD (\n PKD1<\/jats:italic>\n ,\n PKD2<\/jats:italic>\n ), ADPLD (\n PRKCSH<\/jats:italic>\n ,\n SEC63<\/jats:italic>\n ,\n GANAB<\/jats:italic>\n ,\n ALG8<\/jats:italic>\n ,\n SEC61B<\/jats:italic>\n ,\n LRP5<\/jats:italic>\n ), and potential cystic disease modifiers; evaluated variants for quality and annotation; compared variants with data from an ADPKD mutation database; and used bioinformatic tools to predict pathogenicity.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Identification of high-confidence pathogenic mutations in whole-genome sequencing provided a lower boundary for lifetime ADPKD prevalence of 9.3 cases per 10,000 sequenced. Estimates from whole-genome and exome data were similar. Truncating mutations in ADPLD genes and genes of potential relevance as cyst modifiers were found in 20.2 cases and 103.9 cases per 10,000 sequenced, respectively.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Population whole-genome sequencing suggests a higher than expected prevalence of ADPKD-associated mutations. Loss-of-function mutations in ADPLD genes are also more common than expected, suggesting the possibility of unrecognized cases and incomplete penetrance. Substantial rare variation exists in genes with potential for phenotype modification in ADPKD.<\/jats:p>\n <\/jats:sec>","DOI":"10.1681\/asn.2018050493","type":"journal-article","created":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T10:55:53Z","timestamp":1534935353000},"page":"2593-2600","source":"Crossref","is-referenced-by-count":283,"title":["Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing"],"prefix":"10.1681","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5750-6286","authenticated-orcid":false,"given":"Matthew B.","family":"Lanktree","sequence":"first","affiliation":[{"name":"Division of Nephrology, University Health Network, University of Toronto, Toronto, Ontario, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirreza","family":"Haghighi","sequence":"additional","affiliation":[{"name":"Division of Nephrology, University Health Network, University of Toronto, Toronto, Ontario, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Guiard","sequence":"additional","affiliation":[{"name":"Division of Nephrology, University Health Network, University of Toronto, Toronto, Ontario, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioan-Andrei","family":"Iliuta","sequence":"additional","affiliation":[{"name":"Division of Nephrology, University Health Network, University of Toronto, Toronto, Ontario, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewen","family":"Song","sequence":"additional","affiliation":[{"name":"Division of Nephrology, University Health Network, University of Toronto, Toronto, Ontario, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5304-6593","authenticated-orcid":false,"given":"Peter C.","family":"Harris","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9169-118X","authenticated-orcid":false,"given":"Andrew D.","family":"Paterson","sequence":"additional","affiliation":[{"name":"Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada; and"},{"name":"Epidemiology and"},{"name":"Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7858-1093","authenticated-orcid":false,"given":"York","family":"Pei","sequence":"additional","affiliation":[{"name":"Division of Nephrology, University Health Network, University of Toronto, Toronto, Ontario, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2018,8,22]]},"reference":[{"key":"B1-20230829","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1681\/ASN.2015050583","article-title":"Predicted mutation strength of nontruncating PKD1 mutations aids genotype-phenotype correlations in autosomal dominant polycystic kidney disease.","volume":"27","author":"Heyer","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B2-20230829","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1681\/ASN.2015060648","article-title":"Refining genotype-phenotype correlation in autosomal dominant polycystic kidney disease.","volume":"27","author":"Hwang","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B3-20230829","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/14737159.2017.1358088","article-title":"Molecular diagnosis of autosomal dominant polycystic kidney disease.","volume":"17","author":"Song","year":"2017","journal-title":"Expert Rev Mol Diagn"},{"key":"B4-20230829","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1681\/ASN.2017050483","article-title":"Genetic complexity of autosomal dominant polycystic kidney and liver diseases.","volume":"29","author":"Cornec-Le Gall","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"B5-20230829","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1681\/ASN.2006080835","article-title":"Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease.","volume":"17","author":"Harris","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"B6-20230829","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1681\/ASN.2004090758","article-title":"Progressive loss of renal function is an age-dependent heritable trait in type 1 autosomal dominant polycystic kidney disease.","volume":"16","author":"Paterson","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B7-20230829","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1478-3231.2010.02247.x","article-title":"Patients with isolated polycystic liver disease referred to liver centres: Clinical characterization of 137 cases.","volume":"31","author":"Van Keimpema","year":"2011","journal-title":"Liver Int"},{"key":"B8-20230829","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.3748\/wjg.v19.i23.3543","article-title":"Evaluation of hepatic cystic lesions.","volume":"19","author":"Lantinga","year":"2013","journal-title":"World J Gastroenterol"},{"key":"B9-20230829","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1172\/JCI90129","article-title":"Isolated polycystic liver disease genes define effectors of polycystin-1 function.","volume":"127","author":"Besse","year":"2017","journal-title":"J Clin Invest"},{"key":"B10-20230829","first-page":"1","article-title":"Bilateral polycystic disease of the kidneys; a follow-up of two hundred and eighty-four patients and their families.","volume":"328","author":"Dalgaard","year":"1957","journal-title":"Acta Med Scand Suppl"},{"key":"B11-20230829","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0272-6386(83)80044-4","article-title":"Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980.","volume":"2","author":"Iglesias","year":"1983","journal-title":"Am J Kidney Dis"},{"key":"B12-20230829","doi-asserted-by":"crossref","first-page":"e0190430","DOI":"10.1371\/journal.pone.0190430","article-title":"The prevalence of autosomal dominant polycystic kidney disease (ADPKD): A meta-analysis of European literature and prevalence evaluation in the Italian province of Modena suggest that ADPKD is a rare and underdiagnosed condition.","volume":"13","author":"Solazzo","year":"2018","journal-title":"PLoS One"},{"key":"B13-20230829","first-page":"1356","article-title":"Prevalence of autosomal dominant polycystic kidney disease in the European Union.","volume":"32","author":"Willey","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"B14-20230829","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/ndt\/gfs551","article-title":"Epidemiology of autosomal-dominant polycystic kidney disease: An in-depth clinical study for south-western Germany.","volume":"28","author":"Neumann","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"B15-20230829","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/tri.12875","article-title":"Center is an important indicator for choice of invasive therapy in polycystic liver disease.","volume":"30","author":"D\u2019Agnolo","year":"2017","journal-title":"Transpl Int"},{"key":"B16-20230829","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/jhep.2003.50006","article-title":"Clinical profile of autosomal dominant polycystic liver disease.","volume":"37","author":"Qian","year":"2003","journal-title":"Hepatology"},{"key":"B17-20230829","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1399-0004.1986.tb00565.x","article-title":"Adult polycystic liver and kidney diseases are separate entities.","volume":"30","author":"Karhunen","year":"1986","journal-title":"Clin Genet"},{"key":"B18-20230829","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B19-20230829","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans.","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"B20-20230829","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/mgg3.82","article-title":"Diagnosis of autosomal dominant polycystic kidney disease using efficient PKD1 and PKD2 targeted next-generation sequencing.","volume":"2","author":"Trujillano","year":"2014","journal-title":"Mol Genet Genomic Med"},{"key":"B21-20230829","doi-asserted-by":"crossref","first-page":"e0116680","DOI":"10.1371\/journal.pone.0116680","article-title":"An efficient and comprehensive strategy for genetic diagnostics of polycystic kidney disease.","volume":"10","author":"Eisenberger","year":"2015","journal-title":"PLoS One"},{"key":"B22-20230829","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/ejhg.2016.48","article-title":"Whole-genome sequencing overcomes pseudogene homology to diagnose autosomal dominant polycystic kidney disease.","volume":"24","author":"Mallawaarachchi","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"B23-20230829","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13073-017-0403-7","article-title":"Pathogenic variant burden in the ExAC database: An empirical approach to evaluating population data for clinical variant interpretation.","volume":"9","author":"Kobayashi","year":"2017","journal-title":"Genome Med"},{"key":"B24-20230829","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1053\/ajkd.2002.33908","article-title":"Recurrent fetal loss associated with bilineal inheritance of type 1 autosomal dominant polycystic kidney disease.","volume":"40","author":"Paterson","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"B25-20230829","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nature24277","article-title":"Genetic effects on gene expression across human tissues.","volume":"550","author":"Battle","year":"2017","journal-title":"Nature"},{"key":"B26-20230829","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/humu.22911","article-title":"Assessing the pathogenicity of insertion and deletion variants with the Variant Effect Scoring Tool (VEST-Indel).","volume":"37","author":"Douville","year":"2016","journal-title":"Hum Mutat"},{"key":"B27-20230829","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data.","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"B28-20230829","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/bmj.318.7194.1322","article-title":"Reporting of precision of estimates for diagnostic accuracy: A review.","volume":"318","author":"Harper","year":"1999","journal-title":"BMJ"},{"key":"B29-20230829","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/humu.9208","article-title":"Large deletions in the polycystic kidney disease 1 (PKD1) gene.","volume":"23","author":"Ariyurek","year":"2004","journal-title":"Hum Mutat"},{"key":"B30-20230829","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/humu.23320","article-title":"Higher-than-expected population prevalence of potentially pathogenic germline TP53 variants in individuals unselected for cancer history.","volume":"38","author":"de Andrade","year":"2017","journal-title":"Hum Mutat"},{"key":"B31-20230829","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1002\/ijc.30907","article-title":"The prevalence of DICER1 pathogenic variation in population databases.","volume":"141","author":"Kim","year":"2017","journal-title":"Int J Cancer"},{"key":"B32-20230829","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/gim.2016.90","article-title":"Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.","volume":"19","author":"Walsh","year":"2017","journal-title":"Genet Med"},{"key":"B33-20230829","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fped.2017.00080","article-title":"Design and implementation of the hepatorenal fibrocystic disease core center clinical database: A centralized resource for characterizing autosomal recessive polycystic kidney disease and other hepatorenal fibrocystic diseases.","volume":"5","author":"Alzarka","year":"2017","journal-title":"Front Pediatr"},{"key":"B34-20230829","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1097\/01.ASN.0000078805.87038.05","article-title":"Milder presentation of recessive polycystic kidney disease requires presence of amino acid substitution mutations.","volume":"14","author":"Furu","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"B35-20230829","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1681\/ASN.2015050544","article-title":"Hepatocyte nuclear factor 1\u03b2-associated kidney disease: More than renal cysts and diabetes.","volume":"27","author":"Verhave","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B36-20230829","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: Recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference.","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol"},{"key":"B37-20230829","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/bmj.318.7190.1019","article-title":"Tuberous sclerosis.","volume":"318","author":"O\u2019Callaghan","year":"1999","journal-title":"BMJ"},{"key":"B38-20230829","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1086\/318188","article-title":"Bilineal disease and trans-heterozygotes in autosomal dominant polycystic kidney disease.","volume":"68","author":"Pei","year":"2001","journal-title":"Am J Hum Genet"},{"key":"B39-20230829","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1681\/ASN.2010101080","article-title":"Mutations in multiple PKD genes may explain early and severe polycystic kidney disease.","volume":"22","author":"Bergmann","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"B40-20230829","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/j.ajkd.2017.11.015","article-title":"The value of genetic testing in polycystic kidney diseases illustrated by a family with PKD2 and COL4A1 mutations.","volume":"72","author":"Cornec-Le Gall","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"B41-20230829","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1172\/JCI67273","article-title":"Altered trafficking and stability of polycystins underlie polycystic kidney disease.","volume":"124","author":"Cai","year":"2014","journal-title":"J Clin Invest"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201810000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:31:14Z","timestamp":1786131074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201810000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,22]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2018050493","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,22]]}}}